![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/26/2904808/0/en/Neurona-Therapeutics-Appoints-Dr-Nadia-Agopyan-as-Senior-Vice-President-of-Regulatory-Affairs.html
https://www.globenewswire.com/news-release/2024/06/18/2900809/0/en/Neurona-Therapeutics-Receives-FDA-s-Regenerative-Medicine-Advanced-Therapy-RMAT-Designation-for-NRTX-1001-in-Focal-Epilepsy.html
https://www.globenewswire.com/news-release/2024/06/11/2897164/0/en/Neurona-Therapeutics-Appoints-Dr-Manher-Joshi-as-Chief-Medical-Officer.html
https://www.globenewswire.com/news-release/2024/05/28/2888978/0/en/Neurona-Therapeutics-to-Participate-in-Jefferies-Global-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/04/15/2862734/0/en/Neurona-Therapeutics-Presents-Positive-Clinical-Update-from-NRTX-1001-Cell-Therapy-Trial-in-Adults-with-Drug-resistant-Focal-Epilepsy-at-American-Academy-of-Neurology-AAN-2024-Annu.html
https://www.globenewswire.com//news-release/2024/03/12/2844986/0/en/Neurona-Therapeutics-to-Present-at-Stifel-2024-Virtual-CNS-Days.html
https://www.globenewswire.com//news-release/2024/03/07/2842708/0/en/Neurona-Therapeutics-Announces-Presentation-of-Updated-Clinical-Data-at-the-Upcoming-American-Academy-of-Neurology-AAN-Annual-Meeting-from-Lead-Cell-Therapy-Candidate-NRTX-1001.html
https://www.fiercebiotech.com/biotech/dont-call-it-comeback-neurona-knocks-out-120m-raise-year-after-layoffs
https://endpts.com/neurona-raises-120m-to-take-epilepsy-cell-therapy-to-late-stage-development/
https://www.globenewswire.com//news-release/2024/02/07/2825535/0/en/Neurona-Therapeutics-to-Present-at-the-Oppenheimer-34th-Annual-Healthcare-Lifesciences-Conference.html